Improved synthesis of biotinol-5′-AMP: Implications for antibacterial discovery

William Tieu; Steven W. Polyak; Ashleigh S. Paparella; Min Y. Yap; Tatiana P. Soares Da Costa; Belinda Ng; Geqing Wang; Richard Lumb; Jan M. Bell; John D. Turnidge; Matthew C.J. Wilce; Grant W. Booker; Andrew D. Abell

doi:10.1021/ml500475n

Improved synthesis of biotinol-5′-AMP: Implications for antibacterial discovery

William Tieu, Steven W. Polyak, Ashleigh S. Paparella, Min Y. Yap, Tatiana P. Soares Da Costa, Belinda Ng, Geqing Wang, Richard Lumb, Jan M. Bell, John D. Turnidge, Matthew C.J. Wilce, Grant W. Booker, Andrew D. Abell

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

An improved synthesis of biotinol-5′-AMP, an acyl-AMP mimic of the natural reaction intermediate of biotin protein ligase (BPL), is reported. This compound was shown to be a pan inhibitor of BPLs from a series of clinically important bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis, and kinetic analysis revealed it to be competitive against the substrate biotin. Biotinol-5′-AMP also exhibits antibacterial activity against a panel of clinical isolates of S. aureus and M. tuberculosis with MIC values of 1-8 and 0.5-2.5 μg/mL, respectively, while being devoid of cytotoxicity to human HepG2 cells.

Original language	English (US)
Pages (from-to)	216-220
Number of pages	5
Journal	ACS Medicinal Chemistry Letters
Volume	6
Issue number	2
DOIs	https://doi.org/10.1021/ml500475n
State	Published - Feb 12 2015
Externally published	Yes

Keywords

Antibiotics
biotin protein ligase
chemical synthesis
drug design
enzyme inhibitors

ASJC Scopus subject areas

Biochemistry
Drug Discovery
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/ml500475n

Cite this

@article{43c6a53e51584734b4cdad0ee72d04b3,

title = "Improved synthesis of biotinol-5′-AMP: Implications for antibacterial discovery",

abstract = "An improved synthesis of biotinol-5′-AMP, an acyl-AMP mimic of the natural reaction intermediate of biotin protein ligase (BPL), is reported. This compound was shown to be a pan inhibitor of BPLs from a series of clinically important bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis, and kinetic analysis revealed it to be competitive against the substrate biotin. Biotinol-5′-AMP also exhibits antibacterial activity against a panel of clinical isolates of S. aureus and M. tuberculosis with MIC values of 1-8 and 0.5-2.5 μg/mL, respectively, while being devoid of cytotoxicity to human HepG2 cells.",

keywords = "Antibiotics, biotin protein ligase, chemical synthesis, drug design, enzyme inhibitors",

author = "William Tieu and Polyak, {Steven W.} and Paparella, {Ashleigh S.} and Yap, {Min Y.} and {Soares Da Costa}, {Tatiana P.} and Belinda Ng and Geqing Wang and Richard Lumb and Bell, {Jan M.} and Turnidge, {John D.} and Wilce, {Matthew C.J.} and Booker, {Grant W.} and Abell, {Andrew D.}",

note = "Publisher Copyright: {\textcopyright} 2014 American Chemical Society.",

year = "2015",

month = feb,

day = "12",

doi = "10.1021/ml500475n",

language = "English (US)",

volume = "6",

pages = "216--220",

journal = "ACS Medicinal Chemistry Letters",

issn = "1948-5875",

publisher = "American Chemical Society",

number = "2",

}

TY - JOUR

T1 - Improved synthesis of biotinol-5′-AMP

T2 - Implications for antibacterial discovery

AU - Tieu, William

AU - Polyak, Steven W.

AU - Paparella, Ashleigh S.

AU - Yap, Min Y.

AU - Soares Da Costa, Tatiana P.

AU - Ng, Belinda

AU - Wang, Geqing

AU - Lumb, Richard

AU - Bell, Jan M.

AU - Turnidge, John D.

AU - Wilce, Matthew C.J.

AU - Booker, Grant W.

AU - Abell, Andrew D.

PY - 2015/2/12

Y1 - 2015/2/12

N2 - An improved synthesis of biotinol-5′-AMP, an acyl-AMP mimic of the natural reaction intermediate of biotin protein ligase (BPL), is reported. This compound was shown to be a pan inhibitor of BPLs from a series of clinically important bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis, and kinetic analysis revealed it to be competitive against the substrate biotin. Biotinol-5′-AMP also exhibits antibacterial activity against a panel of clinical isolates of S. aureus and M. tuberculosis with MIC values of 1-8 and 0.5-2.5 μg/mL, respectively, while being devoid of cytotoxicity to human HepG2 cells.

AB - An improved synthesis of biotinol-5′-AMP, an acyl-AMP mimic of the natural reaction intermediate of biotin protein ligase (BPL), is reported. This compound was shown to be a pan inhibitor of BPLs from a series of clinically important bacteria, particularly Staphylococcus aureus and Mycobacterium tuberculosis, and kinetic analysis revealed it to be competitive against the substrate biotin. Biotinol-5′-AMP also exhibits antibacterial activity against a panel of clinical isolates of S. aureus and M. tuberculosis with MIC values of 1-8 and 0.5-2.5 μg/mL, respectively, while being devoid of cytotoxicity to human HepG2 cells.

KW - Antibiotics

KW - biotin protein ligase

KW - chemical synthesis

KW - drug design

KW - enzyme inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84922876196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922876196&partnerID=8YFLogxK

U2 - 10.1021/ml500475n

DO - 10.1021/ml500475n

M3 - Article

AN - SCOPUS:84922876196

SN - 1948-5875

VL - 6

SP - 216

EP - 220

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

IS - 2

ER -

Improved synthesis of biotinol-5′-AMP: Implications for antibacterial discovery

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this